Effects of Resistance Training in Body Composition and Body Image Perception of Women Throughout the Menstrual Cycle
NCT ID: NCT04038463
Last Updated: 2021-10-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
6 participants
INTERVENTIONAL
2019-09-01
2020-03-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Resistance Training on Substrate Metabolism During the Menstrual Cycle
NCT04024826
Resistance Training and Sex Hormone Concentrations During the Menstrual Cycle
NCT04163380
Menstrual Cycle Phase Based Training
NCT05936424
Different Menstrual Cycle in Eating Behavior Following Resistance Exercise
NCT06208475
Fatmax Exercise in Menstrual Phases: Effects on Fat Metabolism & Body Composition in NWO Women
NCT06961734
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early Follicular Phase (EFP)
The group will engage in the Resistance Training intervention on the fourth day of their menstrual cycle, which will correlate with the middle of the early follicular phase (EFP).
EFP
This intervention will take place on day 4 of the participants' menstrual cycle. This will correspond to the mid-point of the early follicular phase (EFP).
Late Follicular Phase (LFP)
The group will engage in the Resistance Training intervention on the eleventh day of their menstrual cycle, which will correlate with the middle of the late follicular phase (LFP).
LFP
The intervention will take place on day 8 of the participants' menstrual cycle. This will correspond to the mid-point of the late follicular phase (LFP).
Early Luteal Phase (ELP)
The group will engage in the Resistance Training intervention on the eighteenth of their menstrual cycle, which will correlate with the middle of the early luteal phase (ELP).
ELP
The intervention will take place on day 18 of the participants' menstrual cycle. This will correspond to the mid-point of the early luteal phase (ELP).
Late Luteal Phase (LLP)
The group will engage in the Resistance Training intervention on the twenty-fifth day of their menstrual cycle, which will correlate with the middle of the late luteal phase (LLP).
LLP
The intervention will take place on day 25 of the participants' menstrual cycle. This will correspond to the mid-point of the late luteal phase (LLP).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EFP
This intervention will take place on day 4 of the participants' menstrual cycle. This will correspond to the mid-point of the early follicular phase (EFP).
LFP
The intervention will take place on day 8 of the participants' menstrual cycle. This will correspond to the mid-point of the late follicular phase (LFP).
ELP
The intervention will take place on day 18 of the participants' menstrual cycle. This will correspond to the mid-point of the early luteal phase (ELP).
LLP
The intervention will take place on day 25 of the participants' menstrual cycle. This will correspond to the mid-point of the late luteal phase (LLP).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sedentary or Active
* 18.5-34.9 kg/m2 BMI
* Normal menstrual cycle defined as 28 to 30 days and a duration of 3 to 7 days
* Age range is 18-45 years old
* The inclusion of other participants may alter the results as an increase in body fat has been linked to known changes in different hormonal levels and those changes might influence substrate utilization
* Changes in the hormonal status of pre-menopausal women may appear without symptoms
* Younger females also display variations in their hormones since they are going through the process of development
Exclusion Criteria
* Pregnant females
* Males
* Irregular menstrual cycle, menstrual dysfunction or unusual sex hormone levels
* Musculoskeletal injuries
* Contraceptives, a medication that alters hormonal or cardio-respiratory responses
* Pre-menopausal symptoms
* On moderate to high-intensity exercise regime more than 2 days/week
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Southern Illinois University Edwardsville
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria Fernandez del Valle, PhD
Role: PRINCIPAL_INVESTIGATOR
Southern Illinois University Edwardsville
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Southern Illinois University Edwardsville
Edwardsville, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
160
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.